Latest Therapeutic hypothermia Stories
First Responders Leading the Charge of Cooling Therapy for Cardiac Patients SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies today reported on the growing trend of the country's first responders leading the charge and adopting therapeutic hypothermia protocols for cardiac arrest patients. Newly emerging protocols recommend that cardiac arrest patients be quickly cooled, beginning even before they reach...
SAN DIEGO, Jan. 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies today announced the launch of InnerCool's newly redesigned website at www.innercool.com. The updated and expanded website highlights InnerCool's new RapidBlue(TM) high-performance endovascular temperature modulation system, its CoolBlue(TM) surface system, and CoolConnect Adapters to allow CoolBlue surface pads to be used with other hypothermia consoles....
SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) today reported that Ronald I. Simon (age 70) has retired from the Company's Board of Directors. The resignation reduces the size of Cardium's board to seven directors. "We thank Dr. Simon for his service to the Board and wish him all the best in the years ahead," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics. (Logo:...
Sub-zero U.S. temperatures can put people at risk for hypothermia, or abnormally low body temperature, federal health officials said. Health officials at the Centers for Disease Control and Prevention said that when exposed to cold temperatures, the body begins to lose heat faster than it can be produced, which can result in hypothermia. Body temperature that is too low affects the brain, making the victim unable to think clearly or move well. Hypothermia occurs most commonly at very cold...
SAN DIEGO, Dec. 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) announced that its operating unit InnerCool Therapies, Inc. was awarded a new supplier contract with Novation LLC to introduce InnerCool's RapidBlue endovascular patient temperature modulation system into Novation's extensive network of member health care systems, which includes thousands of hospitals throughout the United States. The agreement, effective January 1, 2009, has a three-year initial...
Best hospitals adhere to trend in medicine favoring non-invasive interventions that minimize needless complications LOUISVILLE, Colo., Dec. 9 /PRNewswire/ -- The nation's top-rated heart programs continue to favor the non-invasive, safe and technologically advanced Arctic Sun Temperature Management System from Medivance for cooling critically ill patients. Cooling comatose cardiac arrest survivors is an evidence-based standard of care recommended by the American Heart Association....
SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext: CXM) and its operating unit InnerCool Therapies today reported on New York City's adoption of procedures designed to promote temperature modulation therapy for cardiac arrest patients, as featured in an article in The New York Times. The article, "City Pushes Cooling Therapy," dated December 4, 2008, reports that New York City ambulances will now be required to transport cardiac arrest patients to...
SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported financial results and highlights for its third quarter ended September 30, 2008, and outlined revised business strategies for its three operating units: (1) InnerCool Therapies, (2) Tissue Repair Company, and (3) Cardium Biologics. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO) InnerCool Therapies, Inc. The Company recently announced 510(k) clearance from the...
SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Cardium Therapeutics and its operating unit InnerCool Therapies, Inc., announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the RapidBlue(TM) System, an endovascular temperature modulation device. InnerCool's RapidBlue System is a thermal regulating system designed to manage and control patient body temperature. This new system automatically cools or warms patients, as necessary, to...
IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Alsius Corporation , the worldwide leader in intravascular temperature management (IVTM(TM)) therapies, today announced that four scientific posters featuring both patient cases and laboratory research in which the Thermogard XP(TM) was utilized will be presented this week at the American Society of Anesthesiologists (ASA) Annual Meeting, taking place in Orlando. Dr. Arie Blitz, Director of Heart Transplantation and Assist Device Surgery at...
